Roivant Sciences Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 245,000 shares at $14.97 ($3.8M) on 2019-12-16, disclosed to the SEC on 2019-12-18.
Open-market purchase of $3.8M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.97 | 131,541 | $2.0M | 52.3% |
| 2 | $15.68 | 38,459 | $603K | 16.0% |
| 3 | $15.94 | 75,000 | $1.2M | 31.7% |
| Total | $15.38 avg | 245,000 | $3.8M | 100% |
| Filing → |
| IMVT | BUY | 2023-10-04 | $58.0M | — | Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |